Search Results - "Dean, Trevano"

A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments by Wallace, David K, Dean, Trevano W, Hartnett, Mary Elizabeth, Kong, Lingkun, Smith, Lois E, Hubbard, G Baker, McGregor, Mary Lou, Jordan, Catherine O, Mantagos, Iason S, Bell, Edward F, Kraker, Raymond T

“…Intravitreal bevacizumab is increasingly used to treat severe retinopathy of prematurity (ROP), but it enters the bloodstream, and there is concern that it may…”
Get full text

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity by Wallace, David K, Kraker, Raymond T, Freedman, Sharon F, Crouch, Eric R, Bhatt, Amit R, Hartnett, M Elizabeth, Yang, Michael B, Rogers, David L, Hutchinson, Amy K, VanderVeen, Deborah K, Haider, Kathryn M, Siatkowski, R Michael, Dean, Trevano W, Beck, Roy W, Repka, Michael X, Smith, Lois E, Good, William V, Kong, Lingkun, Cotter, Susan A, Holmes, Jonathan M

“…Intravitreous bevacizumab (0.25 mg to 0.625 mg) is commonly used to treat type 1 retinopathy of prematurity (ROP), but there are concerns about systemic…”
Get more information

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study by Wallace, David K, Kraker, Raymond T, Freedman, Sharon F, Crouch, Eric R, Hutchinson, Amy K, Bhatt, Amit R, Rogers, David L, Yang, Michael B, Haider, Kathryn M, VanderVeen, Deborah K, Siatkowski, R Michael, Dean, Trevano W, Beck, Roy W, Repka, Michael X, Smith, Lois E, Good, William V, Hartnett, Mary Elizabeth, Kong, Lingkun, Holmes, Jonathan M

“…Intravitreous bevacizumab (0.25 to 0.625 mg) is increasingly used to treat type 1 retinopathy of prematurity (ROP), but there remain concerns about systemic…”
Get more information

A Randomized Trial of Levodopa as Treatment for Residual Amblyopia in Older Children by Repka, Michael X., MD, MBA, Kraker, Raymond T., MSPH, Dean, Trevano W., MPH, Beck, Roy W., MD, PhD, Siatkowski, R. Michael, MD, Holmes, Jonathan M., BM, BCh, Beauchamp, Cynthia L., MD, Golden, Richard P., MD, Miller, Aaron M., MD, MBA, Verderber, Lisa C., MD, Wallace, David K., MD, MPH

“…Objective To assess the efficacy and short-term safety of levodopa as adjunctive treatment to patching for amblyopia. Design Randomized, placebo-controlled…”
Get full text

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants by Hartnett, M Elizabeth, Wallace, David K, Dean, Trevano W, Li, Zhuokai, Boente, Charline S, Dosunmu, Eniolami O, Freedman, Sharon F, Golden, Richard P, Kong, Lingkun, Prakalapakorn, S Grace, Repka, Michael X, Smith, Lois E, Wang, Haibo, Kraker, Raymond T, Cotter, Susan A, Holmes, Jonathan M

“…Intravitreal bevacizumab effectively treats severe retinopathy of prematurity (ROP), but it enters the bloodstream and may reduce serum vascular endothelial…”
Get more information

Visual Acuity and Ophthalmic Outcomes 5 Years After Cataract Surgery Among Children Younger Than 13 Years by Repka, Michael X, Dean, Trevano W, Kraker, Raymond T, Li, Zhuokai, Yen, Kimberly G, de Alba Campomanes, Alejandra G, Young, Marielle P, Rahmani, Bahram, Haider, Kathryn M, Whitehead, George F, Lambert, Scott R, Kurup, Sudhi P, Kraus, Courtney L, Cotter, Susan A, Holmes, Jonathan M

“…Cataract is an important cause of visual impairment in children. Data from a large pediatric cataract surgery registry can provide real-world estimates of…”
Get more information

Cataract Surgery in Children from Birth to Less than 13 Years of Age: Baseline Characteristics of the Cohort by Repka, Michael X, Dean, Trevano W, Lazar, Elizabeth L, Yen, Kimberly G, Lenhart, Phoebe D, Freedman, Sharon F, Hug, Denise, Rahmani, Bahram, Wang, Serena X, Kraker, Raymond T, Wallace, David K

“…To describe baseline characteristics, initial postoperative refractive errors, operative complications, and magnitude of the intraocular lens (IOL) prediction…”
Get full text

Visual Acuity and Ophthalmic Outcomes in the Year After Cataract Surgery Among Children Younger Than 13 Years by Repka, Michael X, Dean, Trevano W, Kraker, Raymond T, Bothun, Erick D, Morrison, David G, Lambert, Scott R, Stahl, Erin D, Wallace, David K

“…Cataract is an important cause of visual impairment in children. Outcomes reported from a large clinical disease-specific registry can provide real-world…”
Get more information

A Randomized Clinical Trial of Immediate versus Delayed Glasses for Moderate Hyperopia in 1- and 2-Year-Olds by Kulp, Marjean T., Holmes, Jonathan M., Dean, Trevano W., Suh, Donny W., Kraker, Raymond T., Wallace, David K., Petersen, David B., Cotter, Susan A., Manny, Ruth E., Superstein, Rosanne, Roberts, Tawna L., Avallone, John M., Fishman, Deborah R., Erzurum, S. Ayse, Leske, David A., Christoff, Alex

“…Two strategies were compared for managing moderate hyperopia without manifest strabismus among 1- and 2-year-old children: (1) immediate prescription of…”
Get full text

A Randomized Clinical Trial of Immediate Versus Delayed Glasses for Moderate Hyperopia in Children 3 to 5 Years of Age by Holmes, Jonathan M., Kulp, Marjean T., Dean, Trevano W., Suh, Donny W., Kraker, Raymond T., Wallace, David K., Petersen, David B., Cotter, Susan A., Crouch, Earl R., Lorenzana, Ingryd J., Ticho, Benjamin H., Verderber, Lisa C., Weise, Katherine K.

“…To compare visual acuity (VA) and binocularity outcomes in moderately hyperopic children with normal VA and binocularity assigned to glasses versus…”
Get full text

Visual Outcomes and Complications After Lensectomy for Traumatic Cataract in Children by Bothun, Erick D, Repka, Michael X, Dean, Trevano W, Gray, Michael E, Lenhart, Phoebe D, Li, Zhuokai, Morrison, David G, Wallace, David K, Kraker, Raymond T, Cotter, Susan A, Holmes, Jonathan M

“…The Pediatric Eye Disease Investigator Group Cataract Registry provides a multicenter assessment of visual outcomes and complications after lensectomy for…”
Get more information

Improvement in health-related quality of life following strabismus surgery for children with intermittent exotropia by Holmes, Jonathan M., Hercinovic, Amra, Melia, B. Michele, Leske, David A., Hatt, Sarah R., Chandler, Danielle L., Dean, Trevano W., Kraker, Raymond T., Enyedi, Laura B., Wallace, David K., Donahue, Sean P., Cotter, Susan A.

“…To investigate health-related quality of life (HRQOL) after strabismus surgery in children with intermittent exotropia (IXT) and relationships between HRQOL…”
Get full text

Health-related quality of life in children with untreated intermittent exotropia and their parents by Holmes, Jonathan M., Hercinovic, Amra, Melia, B. Michele, Leske, David A., Hatt, Sarah R., Chandler, Danielle L., Dean, Trevano W., Kraker, Raymond T., Enyedi, Laura B., Wallace, David K., Mohney, Brian G., Cotter, Susan A.

“…To determine whether health-related quality of life (HRQOL) scores improved or worsened over 3 years of observation in childhood intermittent exotropia without…”
Get full text

A prospective study of treatments for adult-onset divergence insufficiency–type esotropia by Crouch, Eric R., Dean, Trevano W., Kraker, Raymond T., Miller, Aaron M., Kraus, Courtney L., Gunton, Kammi B., Repka, Michael X., Marsh, Justin D., Del Monte, Monte A., Luke, Paula A., Peragallo, Jason H., Lee, Katherine A., Wheeler, Maynard B., Daley, Timothy J., Wallace, David K., Cotter, Susan A., Holmes, Jonathan M.

“…To describe 10-week and 12-month outcomes following treatment for divergence insufficiency–type esotropia in adults. In this prospective observational study,…”
Get full text

Relationship among clinical factors in childhood intermittent exotropia by Superstein, Rosanne, Dean, Trevano W., Holmes, Jonathan M., Chandler, Danielle L., Cotter, Susan A., Wallace, David K., Melia, B. Michele, Kraker, Raymond T., Weaver, R. Grey, Mohney, Brian G., Donahue, Sean P., Birch, Eileen E.

“…To determine the relationships between stereoacuity, control of exotropia, and angle of deviation in children with intermittent exotropia (IXT). Data collected…”
Get full text

Cataract Surgery in Children from Birth to Less than 13 Years of Age by Repka, Michael X., MD, MBA, Dean, Trevano W., MPH, Lazar, Elizabeth L., MSPH, Yen, Kimberly G., MD, Lenhart, Phoebe D., MD, Freedman, Sharon F., MD, Hug, Denise, MD, Rahmani, Bahram, MD, Wang, Serena X., MD, Kraker, Raymond T., MSPH, Wallace, David K., MD, MPH

“…Objective To describe baseline characteristics, initial postoperative refractive errors, operative complications, and magnitude of the intraocular lens (IOL)…”
Get full text

Clinical factors associated with moderate hyperopia in preschool children with normal stereopsis and visual acuity by Suh, Donny W., MD, Kulp, Marjean T., OD, MS, Dean, Trevano W., MPH, Wallace, David K., MD, MPH, Kraker, Raymond T., MSPH, Manny, Ruth E., OD, PhD, Erzurum, Sergul A., MD, Pang, Yi, OD, PhD, Shea, Caroline J., MD, Avallone, John M., MD

“…A total of 117 children 3-5 years of age with moderate hyperopia in at least one eye, age-normal unaided visual acuity, age-normal stereoacuity, no significant…”
Get full text

A Dosing Study of Bevacizumab for Retinopathy of Prematurity by Wallace, David K., Dean, Trevano W., Hartnett, Mary Elizabeth, Kong, Lingkun, Smith, Lois E., Hubbard, G. Baker, McGregor, Mary Lou, Jordan, Catherine O., Mantagos, Iason S., Bell, Edward F., Kraker, Raymond T.

“…Intravitreal bevacizumab is increasingly used to treat severe retinopathy of prematurity (ROP), but it enters the bloodstream, and there is concern that it may…”
Get full text

Pediatric cataract surgery: baseline characteristics of a North American pediatric eye disease registry by Repka, Michael X, Dean, Trevano W, Lazar, Elizabeth L, Freedman, Sharon F, Hug, Denise, Lenhart, Phoebe D, Rahmani, Bahram, Wang, Serena X, Yen, Kimberly G, Kraker, Raymond T

Get full text

Pharmacy Intervention to Improve HIV Testing Uptake Using a Comprehensive Health Screening Approach by Crawford, Natalie D., Dean, Trevano, Rivera, Alexis V., Guffey, Taylor, Amesty, Silvia, Rudolph, Abby, DeCuir, Jennifer, Fuller, Crystal M.

“…Objective. HIV testing is increasingly available, yet barriers to HIV testing persist for low-income black and Latino people, especially those who use illicit…”
Get full text